Skip to main content

Panbela Therapeutics, Inc.

PBLADelisted Apr 25, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001029125

Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Panbela Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
11
+4 vs. Q3 2023
Shares held
152.0K
+94.8K (+165.7%) vs. Q3 2023
Total value
$115.8K
+$43.9K (+61.1%) vs. Q3 2023
New holders
4
3 more added
Sold out
0
1 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PBLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 11 institutions
Q1 2021: 15 institutionsQ2 2021: 17 institutionsQ3 2021: 18 institutionsQ4 2021: 17 institutionsQ1 2022: 16 institutionsQ2 2022: 13 institutionsQ3 2022: 17 institutionsQ4 2022: 15 institutionsQ1 2023: 20 institutionsQ2 2023: 9 institutionsQ3 2023: 7 institutionsQ4 2023: 11 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $115.8K
Q1 2021: $2.74MQ2 2021: $3.12MQ3 2021: $2.41MQ4 2021: $1.72MQ1 2022: $1.78MQ2 2022: $111.0KQ3 2022: $801.0KQ4 2022: $34.5KQ1 2023: $857.7KQ2 2023: $945.1KQ3 2023: $71.8KQ4 2023: $115.8KQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PBLA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202311$115.8K
Q3 20237$71.8K
Q2 20239$945.1K
Q1 202320$857.7K
Q4 202215$34.5K
Q3 202217$801.0K
Q2 202213$111.0K
Q1 202216$1.78M
Q4 202117$1.72M
Q3 202118$2.41M
Q2 202117$3.12M
Q1 202115$2.74M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Panbela Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding PBLA in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP38,144$34.0K0.00%+38,144New
Citadel Advisors LLC34,211$31.3K0.00%−1,645−4.6%Reduced
Geode Capital Management, LLC15,886$14.5K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)15,015$13.7K0.00%+9,575+176.0%Added
JPMorgan Chase & Co12,451$11.4K0.00%+12,451New
Two Sigma Securities, LLC11,689$10.7K0.00%+11,689New
Advisor Group Holdings, Inc.70$630.00%+68+3,400.0%Added
Wells Fargo & Company39$360.00%+17+77.3%Added
Morgan Stanley10$90.00%00.0%Unchanged
Bank of America Corp2$20.00%00.0%Unchanged
Goldman Sachs Group Inc24,513––+24,513New